Clinical Trial Update: Enzastaurin Versus Lomustine in Glioblastoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing enzastaurin to lomustine in glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Enzastaurin (enzastaurin)
• Lomustine (Lomustine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED